ProVise Management Group LLC lowered its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 7.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 21,248 shares of the company’s stock after selling 1,719 shares during the period. ProVise Management Group LLC’s holdings in Colgate-Palmolive were worth $1,932,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Chicago Partners Investment Group LLC raised its stake in shares of Colgate-Palmolive by 16.2% during the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after buying an additional 943 shares during the last quarter. Peak Financial Advisors LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $1,315,000. Fiduciary Alliance LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $4,066,000. Impact Partnership Wealth LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $803,000. Finally, Barclays PLC raised its stake in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after buying an additional 2,132,747 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities analysts recently weighed in on the company. Piper Sandler cut their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Raymond James restated an “outperform” rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Stifel Nicolaus cut their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. UBS Group cut their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Finally, TD Cowen cut their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Hold” and an average price target of $101.72.
Colgate-Palmolive Trading Down 1.4 %
Shares of Colgate-Palmolive stock opened at $89.45 on Wednesday. The stock has a market cap of $72.59 billion, a P/E ratio of 25.41, a P/E/G ratio of 4.20 and a beta of 0.40. The stock’s 50 day simple moving average is $89.13 and its 200-day simple moving average is $94.44. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the firm earned $0.87 EPS. Analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- 3 Warren Buffett Stocks to Buy Now
- 3 Must-Own Stocks to Build Wealth This Decade
- Using the MarketBeat Dividend Yield Calculator
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.